Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Supply of Benzonatate Capsules (100mg)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-5124.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

BENZONATATE CAPSULES

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies Benzonatate Capsules (100mg) for prime contractors on DLA Troop Support Medical Supply Chain Pharm FSA projects. Manufactures or sources pharmaceutical-grade capsules, packages and marks shipments per MIL-STD-129, and applies hazard warning labels per 29 CFR 1910.1200. Requires FDA-approved manufacturing facilities and compliance with the Buy American Act and Berry Amendment. Delivers shipped quantity FOB Destination.

Similar Contracts

Same NAICS industry code

NAICS: 325413
New
DIBBS
LYSING REAGENT
Solicitation # SPE2DS-26-T-445G
Solicitation SPE2DS-26-T-445G is a request for quotes issued by the DLA Troop Support Medical Supply Chain for the acquisition of one unit of cyanide-free lysing reagent, identified by NSN 6550-01-688-9389. This erythrocyte lytic agent is used on DXH 500 series systems for the quantitative determination of hemoglobin and the counting, sizing, and optical measurement of leukocytes. The reagent must be stored between 4 and 25 degrees Celsius and has a non-extendable shelf life of 12 months, with a requirement that no more than one month elapses from the date of manufacture to the date of delivery to the government. The contract specifies that delivery is required within 20 days after order, with FOB, inspection, and acceptance all occurring at the destination. Packaging must be commercial and include suitable sealed unit containers and exterior shipping containers. Marking must comply with Medical Marking Standard No. 1 and MMS1C, including the date of manufacture, expiration or retest date, and the contract or lot number. All quotes must be submitted via the DLA Internet Bid Board System (DIBBS) by September 22, 2026. The procurement incorporates various FAR and DFARS clauses, including requirements for the Buy American Act, basic safeguarding of covered contractor information systems, and the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325413
New
Federal
Promega Assay Reagents to Support Complement-ARIE Mechanistic Toxicology Research
Solicitation # 75N98026Q01226
This solicitation, numbered 75N98026Q01226, is a Request for Quotation for the procurement of specialized Promega assay reagents to support Complement-ARIE mechanistic toxicology research. The research is conducted by the National Center for Advancing Translational Sciences (NCATS) and the National Institute of Environmental Health Sciences (NIEHS) through the Mechanistic Toxicology Branch. These reagents are essential for assessing critical toxicological endpoints, including cell viability, liver injury, liver function, oxidative stress, antioxidant responses, and cellular bioenergetics within human three-dimensional microphysiological systems. The acquisition is being conducted under FAR Part 12 for commercial products using simplified procedures. The government intends to award a firm-fixed-price purchase order on a sole-source basis to Promega Corporation, as they are the only identified manufacturer capable of providing the specific combination of luminescence and chemiluminescence-based detection technologies required to maintain the consistency, comparability, and reproducibility of the established experimental methodology. While the government intends to award to Promega, all responsible sources may submit quotations that demonstrate the ability to satisfy the complete technical requirements. Required supplies, which include various CellTiter-Glo, LDH-Glo, and ROS-Glo assays, must be delivered to the NIEHS laboratory in Research Triangle Park, North Carolina, by September 25, 2026. Acceptance is contingent upon the successful delivery and functional performance of the assays within the NIEHS laboratory environment.
National Institutes Of Health Olao

POSTED

3 days ago

DEADLINE

in 2 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS